For worsening heart failure, the 20 mg group demonstrated a 77% risk reduction (HR, 0.23; 95% CI, 0.07, 0.71; p=0.010), whereas the 80 mg group showed a 61% reduction that did not reach statistical significance (HR, 0.39; 95% CI, 0.10, 1.58; p=0.188; Supplementary Table 6 ).
← all excerpts
Real-World Efficacy of Tafamidis in Korean ATTR-CM Patients: A Retrospective Observational Strain Analysis.
2
0.1880
0.1880
The sentences
LA reservoir strain showed a trend toward greater reduction in the untreated group, but the difference among groups was not statistically significant (p=0.088).